Seattle startup Just Biotherapeutics has nabbed another $14 million to work on affordable biologics with a team lifted from Amgen as well as major backing…

The U.K.’s Cytox announced it launched the research use of its variaTECT genetic biomarker test for assessing the risk of Alzheimer’s disease.

Penumbra, one of the top devicemaker IPOs last year, unveiled its latest thrombectomy product to the U.S. market.

Amsterdam-based contract drug developer Patheon has raised an eye-watering $625 million by offering 29.8 million shares at $21 a pop.

Biogen's CEO steps down, Theranos brings on a team to right its wrongs and FDA's Hall leaves for PatientsLikeMe. Plus more hirings, firings and…

As expected, an FDA panel voted in favor of giving Dexcom’s G5 continuous glucose monitor a nonadjunctive indication that would allow it to be used in place of…

The FDA is not happy with Merck’s monoclonal antibody Clostridium difficile candidate and is demanding more data and analyses from its trials before it can…

This week an FDA panel backed Valeant's skin drug brodalumab and then the regulator gave the thumbs up for an oral version of its constipation drug…